Drug firms facing challenging times due to price control: Cipla
Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products, Cipla Chairman YK Hamied has said.
Sep 29, 2016, 16:04 PM IST